Literature DB >> 19416387

Relapsing polychondritis in a child with common variable immunodeficiency.

Neslihan Edeer Karaca1, Guzide Aksu, Basak Yildiz, Nesrin Gulez, Bengu Turk, Tugrul Dereli, Necil Kutukculer.   

Abstract

Common variable immunodeficiency (CVID) is associated with recurrent infections and autoimmunity. The most common autoimmune conditions are idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, chronic arthritis, and gastrointestinal inflammation. Relapsing polychondritis (RP) is an episodic and progressive systemic inflammatory disease, characterized by auricular chondritis, polyarthritis, nasal, and respiratory tract chondritis. Autoimmunity to cartilage-related components is thought to be involved in its pathogenesis. So far, RP has not been included within many autoimmune conditions that have been reported in patients with either CVID or any other primary immunodeficiency. In this report, a case of CVID with RP and chronic arthritis is presented.

Entities:  

Mesh:

Year:  2009        PMID: 19416387     DOI: 10.1111/j.1365-4632.2009.03809.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  3 in total

Review 1.  Relapsing polychondritis in childhood: three case reports, comparison with adulthood disease and literature review.

Authors:  Adriana R Fonseca; Sheila K F de Oliveira; Marta C F Rodrigues; Ierecê L Aymoré; Romeu C Domingues; Flavio R Sztajnbok
Journal:  Rheumatol Int       Date:  2012-01-01       Impact factor: 2.631

2.  Coexisting relapsing polychondritis and sarcoidosis: an unusual association.

Authors:  Florian Pasquet; Vincent Cottin; Nadia Sivova; Julie Le Scanff; Christiane Broussolle; Pascal Sève
Journal:  Rheumatol Int       Date:  2009-08-28       Impact factor: 2.631

Review 3.  Primary Humoral Immune Deficiencies: Overlooked Mimickers of Chronic Immune-Mediated Gastrointestinal Diseases in Adults.

Authors:  Ida Judyta Malesza; Michał Malesza; Iwona Krela-Kaźmierczak; Aleksandra Zielińska; Eliana B Souto; Agnieszka Dobrowolska; Piotr Eder
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.